Aklillu E - Search Results

1

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.

Khaemba C, Barry A, Omondi WP, Kirui E, Oluka M, Parthasarathi G, Njenga SM, Guantai A, Aklillu E. Khaemba C, et al. Among authors: aklillu e. Drug Saf. 2023 Oct;46(10):961-974. doi: 10.1007/s40264-023-01338-9. Epub 2023 Aug 8. Drug Saf. 2023. PMID: 37552438 Free PMC article.

2

CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans.

Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ. Aklillu E, et al. BMC Infect Dis. 2013 Nov 12;13:536. doi: 10.1186/1471-2334-13-536. BMC Infect Dis. 2013. PMID: 24219137 Free PMC article.

3

Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme.

Chavarria-Soley G, Sticht H, Aklillu E, Ingelman-Sundberg M, Pasutto F, Reis A, Rautenstrauss B. Chavarria-Soley G, et al. Among authors: aklillu e. Hum Mutat. 2008 Sep;29(9):1147-53. doi: 10.1002/humu.20786. Hum Mutat. 2008. PMID: 18470941

4

Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.

Ozdemir V, Aklillu E, Mee S, Bertilsson L, Albers LJ, Graham JE, Caligiuri M, Lohr JB, Reist C. Ozdemir V, et al. Among authors: aklillu e. Expert Opin Pharmacother. 2006 Feb;7(2):119-33. doi: 10.1517/14656566.7.2.119. Expert Opin Pharmacother. 2006. PMID: 16433578 Review.

5

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.

Persson I, Aklillu E, Rodrigues F, Bertilsson L, Ingelman-Sundberg M. Persson I, et al. Among authors: aklillu e. Pharmacogenetics. 1996 Dec;6(6):521-6. doi: 10.1097/00008571-199612000-00005. Pharmacogenetics. 1996. PMID: 9014201

6

Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.

Yasar U, Aklillu E, Canaparo R, Sandberg M, Sayi J, Roh HK, Wennerholm A. Yasar U, et al. Among authors: aklillu e. Eur J Clin Pharmacol. 2002 Nov;58(8):555-8. doi: 10.1007/s00228-002-0518-6. Epub 2002 Nov 1. Eur J Clin Pharmacol. 2002. PMID: 12451434

7

PharmGKB summary: caffeine pathway.

Thorn CF, Aklillu E, McDonagh EM, Klein TE, Altman RB. Thorn CF, et al. Among authors: aklillu e. Pharmacogenet Genomics. 2012 May;22(5):389-95. doi: 10.1097/FPC.0b013e3283505d5e. Pharmacogenet Genomics. 2012. PMID: 22293536 Free PMC article. No abstract available.

8

MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.

Hilli J, Heikkinen T, Rontu R, Lehtimäki T, Kishida I, Aklillu E, Bertilsson L, Vahlberg T, Laine K. Hilli J, et al. Among authors: aklillu e. Eur Neuropsychopharmacol. 2009 May;19(5):363-70. doi: 10.1016/j.euroneuro.2009.01.006. Epub 2009 Feb 14. Eur Neuropsychopharmacol. 2009. PMID: 19223155

9

Recent Progress in Drug Metabolism Research.

Aklillu E, Hidestrand M, Ingelman-Sundberg M, Malmebo S, Westlind A. Aklillu E, et al. Drug News Perspect. 2002 Oct;15(8):528-534. Drug News Perspect. 2002. PMID: 12677192

10

Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles.

Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M. Aklillu E, et al. J Pharmacol Exp Ther. 1996 Jul;278(1):441-6. J Pharmacol Exp Ther. 1996. PMID: 8764380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page